ACTRN12613001039774已完成4 期
Fenofibrate in the Management of Abdominal Aortic Aneurysms 2
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- All
入选标准
- •Ability to provide written informed consent.
- •Diagnosis of an asymptomatic abdominal aortic aneurysm which is infrarenal in location and 35-49mm in size.
- •High likelihood of medication compliance.
排除标准
- •Current use of any fenofibrate or related fibrates contra-indication to fenofibrate including; liver impairment demonstrated by abnormal liver function tests (greater than or equal to 1.5 times normal upper limit); renal impairment (serum creatinine greater than or equal to
- •150 micromole); symptomatic gallbladder disease; previous reaction to any lipid modifying medication.
- •Previous aortic surgery
- •A Mycotic, symptomatic, ruptured or infected abdominal aortic aneurysm
- •A requirement for emergency or urgent open abdominal aortic aneurysm repair
- •Current enrolment in any other drug trial
研究者
相似试验
已完成
4 期
Fenofibrate in the Management of Abdominal Aortic AneurysmsAbdominal Aortic Aneurysm (AAA)Cardiovascular - Diseases of the vasculature and circulation including the lymphatic systemACTRN12612001226897James Cook University42
尚未招募
不适用
Endovascular repair of abdominal aortic aneurysms with hostile necks using the Ovation™ DeviceAbdominal aortic aneurysmACTRN12618000492257Yih Chun Ling Patricia55
已完成
不适用
Abdominal Aortic Aneurysm Sac Healing and Prevention of Endoleaks - A Prospective Multicenter Study.abdominal aortic widening1000318410002363abdominal aortic aneurysmNL-OMON54411Shape Memory Medical15
Unknown
4 期
Eplerenone in the Management of Abdominal Aortic AneurysmsAortic Aneurysm, AbdominalNCT02345590Bayside Health172
已完成
2 期
TElmisartan in the management of abDominal aortic aneurYsm (TEDY)abdominal aortic aneurysm. aneurysm10002363NL-OMON43808eids Universitair Medisch Centrum100